Showing results (2411-2420 of 3,017) with videos related to

Sort By:
Pageof 302
Veterinary Microbiology|July 27, 1999
Nucleotide sequence of UK and Australian isolates of feline calicivirus (FCV) and phylogenetic analysis of FCVsM Glenn, A D Radford, P C Turner, et al.
American Journal of Physiology. Renal Physiology|January 17, 2003
Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporineCan Li, Chul Woo Yang, Wan Young Kim, et al.
Leukemia Research|September 6, 2011
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature reviewMichael J Rauh, Fazlur Rahman, David Good, et al.
BMC Global and Public Health|April 8, 2025
Overview of foodborne hazards associated with inflammation and metabolic healthSrishti Sinha, Laura S Hackl, Samantha L Huey, et al.
Eye (London, England)|January 31, 2015
Residual edema evaluation with ranibizumab 0.5 mg and 2.0 mg formulations for diabetic macular edema (REEF study)D S Dhoot, D J Pieramici, M Nasir, et al.
Arthritis and Rheumatism|February 1, 1990
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria CommitteeF Wolfe, H A Smythe, M B Yunus, et al.
Cancer Treatment Reports|January 1, 1979
VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474)D F Chiuten, J M Bennett, R H Creech, et al.
Cancer|January 15, 1980
Nodular mixed lymphocytic-histiocytic lymphoma (NM): response and survival. Eastern Cooperative Oncology GroupE Z Ezdinli, W G Costello, F Icli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup studyM Grever, K Kopecky, M K Foucar, et al.
Trials|August 30, 2012
Scaling-up from an implementation trial to state-wide coverage: results from the preliminary Melbourne Diabetes Prevention StudyEdward D Janus, James D Best, Nathalie Davis-Lameloise, et al.
Pageof 302